Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Director departure

Hoth Therapeutics, Inc. (HOTH) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/05/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "ARTICLES OF INCORPORATION OF MERVEILLE.AI"
08/21/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
06/06/2023 8-K Other Events  Interactive Data
02/28/2023 8-K Other Events  Interactive Data
12/30/2022 8-K Quarterly results
12/13/2022 8-K Quarterly results
11/10/2022 8-K Quarterly results
11/03/2022 8-K Quarterly results
10/24/2022 8-K Quarterly results
08/22/2022 8-K Quarterly results
07/18/2022 8-K Quarterly results
07/01/2022 8-K Quarterly results
06/23/2022 8-K Quarterly results
06/13/2022 8-K Quarterly results
04/29/2022 8-K Quarterly results
04/13/2022 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "8,235,294 SHARES of Common Stock Hoth Therapeutics, Inc.",
"LEGAL OPINION OF SHEPPARD MULLIN RICHTER & HAMPTON, LLP",
"Hoth Therapeutics, Inc. Announces Proposed Public Offering of Common Stock",
"Hoth Therapeutics, Inc. Announces Pricing of $7.0 Million Underwritten Public Offering Priced At-The-Market"
04/05/2022 8-K Other Events  Interactive Data
01/21/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/07/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
01/04/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial ...
Docs: "Hoth Therapeutics Announces HT-ALZ Therapeutic Shows Positive Results - Reduce Amyloid β in Alzheimer’ s Disease"
12/08/2021 8-K Quarterly results
09/01/2021 8-K Quarterly results
08/26/2021 8-K Quarterly results
06/30/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "FIRST AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT This First Amendment to the Amended and Restated Employment Agreement dated as of June 25, 2021, and effective as of July 1, 2021, is entered into between by and between Hoth Therapeutics, a Nevada corporation , and Robb Knie . All capitalized terms used herein but not otherwise defined shall have the meanings set forth in the Agreement . WHEREAS, the Corporation and Executive entered into that certain Amended and Restated Employment Agreement dated as of February 20, 2019 ; and WHEREAS, the Company and Executive desire to make certain amendments to the Agreement as set forth herein. NOW THEREFORE, in consideration of the above, and for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, ...",
"SECOND AMENDMENT TO EMPLOYMENT AGREEMENT",
"FIRST AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT",
"Investor Contact: LR Advisors LLC Email:"
06/17/2021 8-K Other Events
05/24/2021 8-K Quarterly results
05/07/2021 8-K Quarterly results
04/15/2021 8-K Quarterly results
03/09/2021 8-K Quarterly results
02/24/2021 8-K Quarterly results
01/29/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "FIRST AMENDMENT TO EMPLOYMENT AGREEMENT"
01/25/2021 8-K Other Events, Financial Statements and Exhibits
Docs: "Presentation Materials"
01/08/2021 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Certain Office...
Docs: "Form of Securities Purchase Agreement",
"Form of Warrant",
"Form of Registration Rights Agreement",
"Form of Placement Agent Warrant",
"/ PR Newswire/",
"Hoth Therapeutics Announces Private Placement of Equity Priced At-The-Market Under Nasdaq Rules"
12/08/2020 8-K Other Events
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy